MicroRNAs (
miRNAs) contribute to
tumorigenesis and progression via acting as
tumor suppressors or oncogenes in human
cancer. Aberrant expression of miR-302c has been reported in various types of
cancer except
colorectal cancer (CRC). Thus, our study was aimed to verify the expression of miR-302c and its functional role in CRC. We found a significant reduced expression of miR-302c in CRC tissues compared to
tumor-adjacent tissues. Low miR-302c level was remarkably correlated with deeper
tumor invasion,
lymph node metastasis and advanced TNM stage. Importantly, low miR-302c expression was identified as an independent
indicator for poor prognosis of CRC patients. Overexpression of miR-302c repressed migration and invasion capacities of SW620 and SW480 cells in vitro. Mechanistically, miR-302c inversely regulated
transcription factor AP4 (TFAP4) abundance in both SW620 and SW480 cells, and it negatively correlated with TFAP4
mRNA expression in CRC samples. Herein, TFAP4, a regulator of epithelial-mesenchymal transition (EMT), was recognized as a direct target gene of miR-302c in CRC. Otherwise, miR-302c overexpression increased
E-cadherin expression and reduced the levels of
Vimentin and SNAI1, suggesting an inhibitory effect of miR-302c on EMT of CRC cells. Notably, our findings established that the EMT and
metastasis of Caco-2 cells were enhanced by miR-302c knockdown, and subsequently reversed by TFAP4 silencing. Collectively, these data indicate that miR-302c represses EMT and CRC
metastasis possibly by targeting TFAP4, and it may serve as a potential prognostic factor and therapeutic target for CRC.